Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Completed × KB004 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Paclitaxel 248 Cisplatin 222 Gemcitabine 217 Carboplatin 213 Cyclophosphamide 195 Radiotherapy 183 Irinotecan 156 pembrolizumab 144 Docetaxel 144 Bevacizumab 144 Capecitabine 126 Nivolumab 120 Fluorouracil 109 Dexamethasone 108 Erlotinib Hydrochloride 104 Bortezomib 103 Cytarabine 100 Sorafenib 98 Oxaliplatin 98 Temozolomide 93 Filgrastim 93 Doxorubicin 92 Etoposide 90 Leucovorin 88 Rituximab 86 Lenalidomide 83 Everolimus 82 Pemetrexed 75 Ipilimumab 73 fludarabine phosphate 72

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03374943 2021-11-04

A Trial of KB004 in Patients With Glioblastoma

Olivia Newton-John Cancer Research Institute

Phase 1 Completed

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡